跳至主要内容
临床试验/IRCT20200518047497N2
IRCT20200518047497N2尚未招募3 期

Effect of Dinvl medicinal herb on improving of clinical and paraclinical symptoms in patients with COVID-19 :A Randomized Controlled Trial

Zahravi Pharmaceutical Company0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 no limit(—)
性别
All

入选标准

  • COVID-19 patients aged 15 years and older who newly admitted (first day of hospitalization)
  • Having definite COVID-19 disease
  • Obtaining informed consent to participate in the trial
  • Non-participation in another clinical trial simultaneously

排除标准

  • Having liver or renal failure according to the patient's statement, physician examination or based on creatinine, SGOT, SGPT, LDH tests.
  • Immunodeficiency (treated with Corticosteroids over 12.5 mg / d Prednisolone for more than two weeks, chemotherapy, malignancies, organ transplants, HIV patients, other viral diseases.
  • Having other infectious diseases according to the diagnosis of the physician and the information of medical record.
  • Pregnancy (according to the patient's statement and examination by a physician).
  • Breastfeeding (according to the patient's statement).

研究者

相似试验